Melissa Conerly

Melissa Conerly has extensive experience in the biotechnology and cancer research fields. Melissa currently works as a Principal Scientist at Generate Biomedicines since 2023. Previously, from 2019 to 2022, they held the role of Principal Scientist at Seagen. During their time at Seagen, they also served as a Senior Scientist from 2019 to 2023. Prior to that, Melissa worked at OncoResponse as a Scientist from 2017 to 2019, where they led a team in immune-oncology programs and monoclonal antibody characterization. Melissa obtained their postdoctoral research fellowship at Fred Hutchinson Cancer Research Center from 2010 to 2016, focusing on therapeutic modalities for muscular dystrophy. Melissa's graduate work was conducted at Fred Hutchinson Cancer Research Center from 2002 to 2010, where they studied tumorigenesis and collaborated with mouse tumor model specialists. Melissa also worked as a Teaching Assistant at the University of Washington in 2004, teaching cancer genetics. Prior to that, Melissa worked as a Research Associate II at Ceres, Inc. from 1999 to 2002, where they investigated root development in Arabidopsis for crop applications using genetic technologies. Melissa'sresearch career started as a Research Assistant I at the University of California, Riverside from 1998 to 1999.

Melissa Conerly holds a Ph.D in Molecular and cellular biology from the University of Washington, which they obtained from 2002 to 2010. Melissa also received a B.S. in Biology from the University of California, Riverside, from 1995 to 1999. Melissa Conerly has obtained additional certifications in various areas, such as Using Databases with Python, Using Python to Access Web Data, Genomic Data Science with Galaxy, Programming for Everybody (Python), and Using Case Studies in Teaching.